Skip to main content

ACRIN-FMISO-BRAIN

By
DOI: 10.7937/K9/TCIA.2018.vohlekok | Image Collection

The objective of the ACRIN 6684 multi-center clinical trial was to determine the association of baseline FMISO PET uptake (maximal tumor to blood ratio, hypoxic volume) and MRI parameters (Ktrans, CBV) with overall survival, time to disease progression, and 6-month progression free survival in participants with newly diagnosed glioblastoma multiforme (GBM). The trial also collected standard brain...

Read More

ACRIN-DSC-MR-BRAIN

By
DOI: 10.7937/tcia.2019.zr1pjf4i | Image Collection

RTOG 0625/ACRIN 6677 is a multicenter, randomized, phase II trial of bevacizumab with irinotecan or temozolomide in recurrent glioblastoma (GBM). This study investigated whether early posttreatment progression on FLAIR or postcontrast MRI assessed by central reading predicts overall survival (OS).

METHODS:

Of 123 enrolled patients, 107 had baseline and at least 1 posttreatment MRI. Two central neuroradiologists...

Read More

ACRIN-CONTRALATERAL-BREAST-MR

By
DOI: 10.7937/Q1EE-J082 | Image Collection

This dataset relates to NCI Clinical trial, "Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer (ACRIN-6667)". The dataset consists of 984 patients but only 969 were included in the primary data analysis due to study criteria.

Even after careful clinical and mammographic evaluation, cancer is found in the contralateral...

Read More

STAGEII-COLORECTAL-CT

By
DOI: 10.7937/p5k5-tg43 | Image Collection

This dataset includes abdominal or pelvic enhanced CT images within 10 days before surgery of 230 patients with stage II colorectal cancer (CRC). The inclusion criteria were as follows: (i) patients with radical surgery for CRC (complete removal of the original tumor and regional lymphadenectomy); (ii) patients with stage II CRC confirmed by histology and pathology; (iii) abdominal or pelvic enhanced CT examination...

Read More

EA1141

By
DOI: 10.7937/2BAS-HR33 | Image Collection

This collection contains data from the Eastern Cooperative Oncology Group (ECOG) Clinical Trial NCT02933489, “Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts". Principal Investigator: Christopher Comstock.  It was sponsored by NCI and performed by the Eastern Cooperative Oncology Group under study...

Read More

PCA_BX_3DPATHOLOGY

By
DOI: 10.7937/44MA-GX21 | Image Collection

This collection provides public access to a 3D pathology dataset of prostate cancer, allowing researchers to further investigate various 3D tissue structures and their correlation with prostate cancer patient outcomes (biochemical recurrence). These 3D tissue structures are revealed through: (1) a H&E-analog stain, (2) synthetically generated immunofluorescence staining of CK8 (targeting the luminal epithelial...

Read More

AML-CYTOMORPHOLOGY_MLL_HELMHOLTZ

By
DOI: 10.7937/6PPE-4020 | Image Collection

This dataset comprises four prevalent AML subtypes with defining genetic abnormalities and typical morphological features according to the WHO 2022 classification: (i) APL with PML::RARA fusion, (ii) AML with NPM1 mutation, (iii) AML with CBFB::MYH11 fusion (without NPM1 mutation), and (iv) AML with RUNX1::RUNX1T1 fusion, as well as a control group of healthy stem cell donors. 

A total of 189 peripheral blood...

Read More